Transfusion-Associated Graft-Versus-Host Disease

Transfusion Medicine Reviews

Volumn 23, Issue 1, 2009, Pages 62-71

  Rühl, Heiko ^a   Bein, Gregor ^a   Sachs, Ulrich J H ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE; OKT 3; THYMOCYTE ANTIBODY;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CHROMOSOME ANALYSIS; CLINICAL FEATURE; EXCHANGE BLOOD TRANSFUSION; GAMMA IRRADIATION; GRAFT VERSUS HOST REACTION; GRANULOCYTE TRANSFUSION; HUMAN; IMMUNE DEFICIENCY; INTRAUTERINE BLOOD TRANSFUSION; LEUKAPHERESIS; LYMPHOMA; MICROSATELLITE MARKER; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PREMATURITY; REVIEW; SHORT TANDEM REPEAT; SOLID TUMOR; STEM CELL TRANSPLANTATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BLOOD DONORS; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; COMMON VARIABLE IMMUNODEFICIENCY; GRAFT VS HOST DISEASE; HLA ANTIGENS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NEOPLASMS; ORGAN TRANSPLANTATION; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES;

EID: 56849132135     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2008.09.006     Document Type: Review

References (137)

1. Lee T.H., Donegan E., Slichter S., et al. Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. Blood 85 (1995) 1207-1214
2. Ferrara J.L., and Reddy P. Pathophysiology of graft-versus-host disease. Semin Hematol 43 (2006) 3-10
3. Ferrara J.L., and Yanik G. Acute graft versus host disease: Pathophysiology, risk factors, and prevention strategies. Clin Adv Hematol Oncol 3 (2005) 415-419
4. Vogelsang G.B. Transfusion-associated graft-versus-host disease in nonimmunocompromised hosts. Transfusion 30 (1990) 101-103
5. + T-cell clones. Blood 89 (1997) 1440-1445
6. Nishimura M., Uchida S., Mitsunaga S., et al. Identification of HLA class II antigens as the targets of effector clones which may cause transfusion-associated graft-versus-host disease. Transfus Med 7 (1997) 89-94
7. Vogelsang G.B., and Hess A.D. Graft-versus-host disease: New directions for a persistent problem. Blood 84 (1994) 2061-2067
8. Nishimura M., Uchida S., Mitsunaga S., et al. Evidence of involvement of cytotoxic antibodies directed against patients's HLA class II produced by transfused donor-derived B cells in post-transfusion graft-versus-host disease. Br J Haematol 92 (1996) 1011-1013
9. Ohto H., Yasuda H., Noguchi M., et al. Risk of transfusion-associated graft-versus-host disease as a result of directed donations from relatives. Transfusion 32 (1992) 691-693
10. Ohto H., and Anderson K.C. Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfus Med Rev 10 (1996) 31-43
11. Ohto H., and Anderson K.C. Posttransfusion graft-versus-host disease in Japanese newborns. Transfusion 36 (1996) 117-123
12. Juji T., Takahashi K., Shibata Y., et al. Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan. N Engl J Med 321 (1989) 56
13. Anderson K.C., and Weinstein H.J. Transfusion-associated graft-versus-host disease. N Engl J Med 323 (1990) 315-321
14. Greenbaum B.H. Transfusion-associated graft-versus-host disease: Historical perspectives, incidence, and current use of irradiated blood products. J Clin Oncol 9 (1991) 1889-1902
15. Schroeder M.L. Transfusion-associated graft-versus-host disease. Br J Haematol 117 (2002) 275-287
16. Thaler M., Shamiss A., Orgad S., et al. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery. N Engl J Med 321 (1989) 25-28
17. Petz L.D., Calhoun L., Yam P., et al. Transfusion-associated graft-versus-host disease in immunocompetent patients: Report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors. Transfusion 33 (1993) 742-750
18. Aoun E., Shamseddine A., Chehal A., et al. Transfusion-associated GvHD: 10 years' experience at the American University of Beirut-Medical Center. Transfusion 43 (2003) 1672-1676
19. Serefhanoglu K., Turan H., Saba T., et al. Transfusion-associated graft-versus-host disease in an immunocompetent individual following cardiac surgery. J Natl Med Assoc 97 (2005) 418-420
20. Aybey B., Coskun D., and Aytac J. Transfusion associated graft versus host disease following cardiovascular surgery. Mikrobiyol Bul 40 (2006) 103-107
21. Sohi I., and Jacob S. Transfusion associated GvHD. Indian J Pediatr 72 (2005) 533-535
22. Wagner F.F., and Flegel W.A. Transfusion-associated graft-versus-host disease: Risk due to homozygous HLA-haplotypes. Transfusion 35 (1995) 284-291
23. Benson K., Marks A.R., Marshall M.J., et al. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors. Transfusion 34 (1994) 432-437
24. Kita T., Nei J., Matsu T., et al. GvHD after transfusion of stored RBC concentrates in a solution of mannitol, adenine, phosphate, citrate, glucose, and NaCl following trauma. Transfusion 40 (2000) 297-301
25. O'Connor N.T., and Mackintosh P. Transfusion associated graft versus host disease in an immunocompetent patient. J Clin Pathol 45 (1992) 621-622
26. Triulzi D., Duquesnoy R., Nichols L., et al. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Transfusion 46 (2006) 885-888
27. Gorman T.E., Julius C.J., Barth R.F., et al. Transfusion-associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donor. Am J Clin Pathol 113 (2000) 732-737
28. Shivdasani R.A., and Anderson K.C. Transfusion-associated graft-versus-host disease: Scratching the surface. Transfusion 33 (1993) 696-697
29. Sanders M.R., and Graeber J.E. Posttransfusion graft-versus-host disease in infancy. J Pediatr 117 (1990) 159-163
30. Perkins H.A. Granulocyte concentrates: Should they be routinely irradiated?. Prog Clin Biol Res 65 (1981) 49-57
31. Ford J.M., Cullen M.H., Lucey J.J., et al. Fatal graft-versus-host disease following transfusion of granulocytes from normal donors. Lancet 2 (1976) 1167-1169
32. Weiden P. Graft-v-host disease following blood transfusions. Arch Intern Med 144 (1984) 1557-1558
33. Weiden P.L., Zuckerman N., Hansen J.A., et al. Fatal graft-versus-host disease in a patient with lymphoblastic leukemia following normal granulocyte transfusion. Blood 57 (1981) 328-332
34. Schmidmeier W., Feil W., Gebhart W., et al. Fatal graft-versus-host reaction following granulocyte transfusions. Blut 45 (1982) 115-119
35. Tolbert B., Kaufman Jr. C.E., Burgdorf W.H., et al. Graft-versus-host disease from leukocyte transfusions. J Am Acad Dermatol 9 (1983) 416-419
36. Naiman J.L., Punnett H.H., Lischner H.W., et al. Possible graft-versus-host reaction after intrauterine transfusion for Rh erythroblastosis fetalis. N Engl J Med 281 (1969) 697-701
37. Parkman R., Mosier D., Umansky I., et al. Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn. N Engl J Med 290 (1974) 359-363
38. Hentschel R., Broecker E.B., Kolde G., et al. Intact survival with transfusion-associated graft-versus-host disease proved by human leukocyte antigen typing of lymphocytes in skin biopsy specimens. J Pediatr 126 (1995) 61-64
39. Bohm N., Kleine W., and Enzel U. Graft-versus-host disease in two newborns after repeated blood transfusions because of rhesus incompatibility. Beitr Pathol 160 (1977) 381-400
40. Lauer B.A., Githens J.H., Hayward A.R., et al. Probable graft-vs-graft reaction in an infant after exchange transfusion and marrow transplantation. Pediatrics 70 (1982) 43-47
41. Seemayer T.A., and Bolande R.P. Thymic involution mimicking thymic dysplasia: A consequence of transfusion-induced graft versus host disease in a premature infant. Arch Pathol Lab Med 104 (1980) 141-144
42. Flidel O., Barak Y., Lifschitz-Mercer B., et al. Graft versus host disease in extremely low birth weight neonate. Pediatrics 89 (1992) 689-690
43. Hathaway W.E., Githens J.H., Blackburn W.R., et al. Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children. Probable human runt disease. N Engl J Med 273 (1965) 953-958
44. van Royen-Kerkhof A., Wulffraat N.M., Kamphuis S.S., et al. Nonlethal transfusion associated graft-versus-host disease in a severe combined immunodeficient patient. Bone Marrow Transplant 32 (2003) 1027-1030
45. Friedman D.F., Kwittken P., Cizman B., et al. DNA-based HLA typing of nonhematopoietic tissue used to select the marrow transplant donor for successful treatment of transfusion-associated graft-versus-host disease. Clin Diagn Lab Immunol 1 (1994) 590-596
46. Park B.H., Good R.A., Gate J., et al. Fatal graft-vs.-host reaction following transfusion of allogeneic blood and plasma in infants with combined immunodeficiency disease. Transplant Proc 6 (1974) 385-387
47. Brouard J., Morin M., Borel B., et al. Di George's syndrome complicated by graft versus host reaction. Arch Fr Pediatr 42 (1985) 853-855
48. Wintergerst U., Meyer U., Remberger K., et al. Graft versus host reaction in an infant with DiGeorge syndrome. Monatsschr Kinderheilkd 137 (1989) 345-347
49. Douglas S.D., and Fudenberg H.H. Graft versus host reaction in Wiskott-Aldrich syndrome: antemortem diagnosis of human GVH in an immunologic deficiency disease. Vox Sang 16 (1969) 172-178
50. Watson H.G., McLaren K.M., Todd A., et al. Transfusion-associated graft-versus-host disease in ataxia telangiectasia. Lancet 349 (1997) 179
51. Strobel S., Morgan G., Simmonds A.H., et al. Fatal graft versus host disease after platelet transfusions in a child with purine nucleoside phosphorylase deficiency. Eur J Pediatr 148 (1989) 312-314
52. Hathaway W.E., Brangle R.W., Nelson T.L., et al. Aplastic anemia and alymphocytosis in an infant with hypogammaglobulinemia: Graft-versus-host reaction?. J Pediatr 68 (1966) 713-722
53. Thomas E.D., Herman Jr. E.C., Greenough III W.B., et al. Irradiation and marrow infusion in leukemia. Observations in five patients with acute leukemia treated by whole-body exposures of 1,400 to 2,000 roentgens and infusions of marrow. Arch Intern Med 107 (1961) 829-845
54. Postmus P.E., Mulder N.H., and Elema J.D. Graft versus host disease after transfusions of non-irradiated blood cells in patients having received autologous bone marrow. A report of 4 cases following ablative chemotherapy for solid tumors. Eur J Cancer Clin Oncol 24 (1988) 889-894
55. von Fliedner V.E., Higby D.J., and Kim U. Graft-versus-host reaction following blood product transfusion. Am J Med 72 (1982) 951-961
56. Kessinger A., Armitage J.O., Klassen L.W., et al. Graft versus host disease following transfusion of normal blood products to patients with malignancies. J Surg Oncol 36 (1987) 206-209
57. Decoste S.D., Boudreaux C., and Dover J.S. Transfusion-associated graft-vs-host disease in patients with malignancies. Report of two cases and review of the literature. Arch Dermatol 126 (1990) 1324-1329
58. Ekert H., Waters K.D., Smith P.J., et al. Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease. J Clin Oncol 6 (1988) 1845-1850
59. Mathe G., Schwarzenberg L., de Vries M.J., et al. The various aspects of the secondary syndrome complicating allogeneic bone marrow transplantations or leukocyte transfusions in patients suffering from malignant hemopathies. Eur J Cancer 1 (1965) 75-113
60. Groff P., Torhorst J., Speck B., et al. Graft versus host disease, a little known complication of blood transfusion. Schweiz Med Wochenschr 106 (1976) 634-639
61. Dinsmore R.E., Straus D.J., Pollack M.S., et al. Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing. Blood 55 (1980) 831-834
62. Burns L.J., Westberg M.W., Burns C.P., et al. Acute graft-versus-host disease resulting from normal donor blood transfusions. Acta Haematol 71 (1984) 270-276
63. Baglin T.P., Joysey V.C., Horsford J., et al. Transfusion-associated graft-versus-host disease in patients with Hodgkin's disease and T cell lymphoma. Transfus Med 2 (1992) 195-199
64. Heim M.U., Munker R., Sauer H., et al. Graft versus host disease with fatal outcome after administration of filtered erythrocyte concentrates. Beitr Infusionsther 30 (1992) 178-181
65. Kunstmann E., Bocker T., Roewer L., et al. Diagnosis of transfusion-associated graft-versus-host disease by genetic fingerprinting and polymerase chain reaction. Transfusion 32 (1992) 766-770
66. Lillevang S.T., Andersen C.B., Schmidt K.G., et al. Transfusion-associated graft-vs-host disease in a patient with Hodgkin's disease. Ugeskr Laeger 154 (1992) 2979-2980
67. Nakamoto T., Nishi S., Shindoh M., et al. A case of graft-versus-host disease following red cell concentrate (MAP-CRC) transfusion. Masui 44 (1995) 1261-1264
68. Spitzer T.R., Cahill R., Cottler-Fox M., et al. Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature. Cancer 66 (1990) 2346-2349
69. Tomas Martinez J.F., Abad Hernandez M.J., Cortina de la Calle M.P., et al. Post-transfusion graft versus host disease in a patient with Hodgkin's disease. Med Clin (Barc) 92 (1989) 503-506
70. Akahoshi M., Takanashi M., Masuda M., et al. A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters. Transfusion 32 (1992) 169-172
71. Garcia Gala J.M., Ramirez Payer A., Rayon C., et al. Chronic posttransfusion graft-vs-host disease in a patient with non-Hodgkin's lymphoma. Sangre (Barc) 38 (1993) 489-491
72. Gossi U., Bucher U., Brun del Re G., et al. Acute graft-versus-host disease following a single transfusion of erythrocytes. Schweiz Med Wochenschr 115 (1985) 34-40
73. Hull R.J., Bray R.A., Hillyer C., et al. Transfusion-associated chronic cutaneous graft-versus-host disease. J Am Acad Dermatol 33 (1995) 327-332
74. Munro L.R., Culligan D.J., Grant A., et al. Transfusion-associated graft-versus-host disease in a patient with Waldenstrom's macroglobulinaemia. Vox Sang 83 (2002) 279-281
75. Appleton A.L., Sviland L., Pearson A.D., et al. Diagnostic features of transfusion associated graft versus host disease. J Clin Pathol 47 (1994) 541-546
76. Mutasim D.F., Badr K., Saab G., et al. Graft-versus-host disease in a patient with acute lymphoblastic lymphoma. Cutis 33 (1984) 206-210
77. Saab G.A., Kurban A.K., and Mutasim D.F. Graft-versus-host disease in lymphoblastic lymphoma following blood transfusions. Middle East J Anesthesiol 7 (1983) 221-225
78. Gelly K.J., Kerr R., Rawlinson S., et al. Transfusion-associated graft vs. host disease in a patient with high-grade B-cell lymphoma. Should cellular products for patients with non-Hodgkin's lymphoma be irradiated?. Br J Haematol 110 (2000) 228-229
79. Cheson B.D. Infectious and immunosuppressive complications of purine analog therapy. J Clin Oncol 13 (1995) 2431-2448
80. Briz M., Cabrera R., Sanjuan I., et al. Diagnosis of transfusion-associated graft-versus-host disease by polymerase chain reaction in fludarabine-treated B-chronic lymphocytic leukaemia. Br J Haematol 91 (1995) 409-411
81. Deane M., Gor D., Macmahon M.E., et al. Quantification of CMV viraemia in a case of transfusion-related graft-versus-host disease associated with purine analogue treatment. Br J Haematol 99 (1997) 162-164
82. Hutchinson K., Kopko P.M., Muto K.N., et al. Early diagnosis and successful treatment of a patient with transfusion-associated GvHD with autologous peripheral blood progenitor cell transplantation. Transfusion 42 (2002) 1567-2572
83. Maung Z.T., Wood A.C., Jackson G.H., et al. Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia. Br J Haematol 88 (1994) 649-652
84. Arico M., Noto G., Pravata G., et al. Transfusion-associated graft-versus-host disease-report of two further cases with an immunohistochemical analysis. Clin Exp Dermatol 19 (1994) 36-42
85. Leitman S.F., Tisdale J.F., Bolan C.D., et al. Transfusion-associated GvHD after fludarabine therapy in a patient with systemic lupus erythematosus. Transfusion 43 (2003) 1667-1671
86. Strauss R.G. Data-driven blood banking practices for neonatal RBC transfusions. Transfusion 40 (2000) 1528-1540
87. Klein C., Fraitag S., Foulon E., et al. Moderate and transient transfusion-associated cutaneous graft-versus-host disease in a child infected by human immunodeficiency virus. Am J Med 101 (1996) 445-446
88. Mayer K. Transfusion of the patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 114 (1990) 295-297
89. Popovsky M.A., Benson K., Glassman A.B., et al. Transfusion practices in human immunodeficiency virus-infected patients. Transfusion 35 (1995) 612-616
90. Berkel A.I., and Tinaztepe K. Graft-versus-host reaction manifested as toxic epidermal necrolysis in a patient with acute leukemia. Turk J Pediatr 23 (1981) 37-41
91. Cohen D., Weinstein H., Mihm M., et al. Nonfatal graft-versus-host disease occurring after transfusion with leukocytes and platelets obtained from normal donors. Blood 53 (1979) 1053-1057
92. Gartner J.G. Thymic involution with loss of Hassall's corpuscles mimicking thymic dysplasia in a child with transfusion-associated graft-versus-host disease. Pediatr Pathol 11 (1991) 449-456
93. Lowenthal RM, Challis DR, Griffiths AE, et al: Transfusion-associated graft-versus-host disease: Report of an occurrence following the administration of irradiated blood. Transfusion 33:524-529
94. Nikoskelainen J., Soderstrom K.O., Rajamaki A., et al. Graft-versus-host reaction in 3 adult leukaemia patients after transfusion of blood cell products. Scand J Haematol 31 (1983) 403-409
95. Hayakawa S., Chishima F., Sakata H., et al. A rapid molecular diagnosis of posttransfusion graft-versus-host disease by polymerase chain reaction. Transfusion 33 (1993) 413-417
96. Ito K., Fujita M., Norioka M., et al. Postoperative erythroderma with change of HLA phenotypes from heterozygotes to homozygotes: a report of two cases. Eur J Haematol 46 (1991) 217-222
97. Kumamoto H., Abe K., Sawai T., et al. Transfusion-associated graft-versus-host disease diagnosed by polymerase chain reaction analysis of DNA microsatellites: An autopsy case with immunohistochemical investigation. Tohoku J Exp Med 179 (1996) 281-289
98. Kosuga K., Ohgami N., Okuda K., et al. Transfusion-associated graft versus host disease following hepatectomy for hepatocellular carcinoma-a case report. Kurume Med J 40 (1993) 193-199
99. Mineta H., Sakai T., Suzuki I., et al. A case of transfusion-associated GvHD after total laryngectomy. Nippon Jibiinkoka Gakkai Kaiho 95 (1992) 891-897
100. Ryo R., Saigo K., Hashimoto M., et al. Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor. Vox Sang 76 (1999) 241-246
101. Ryo R., Goto M., Takada M., et al. Diagnosis of post-transfusion graft-versus-host disease after formalin-fixation. Int J Hematol 59 (1994) 297-302
102. Sakai H., Miyakawa H., Daiguji Y., et al. Hepatic involvement in graft-versus-host disease associated with blood transfusion. Jpn J Med 29 (1990) 633-636
103. Saito M., Takamatsu H., Nakao S., et al. Transfusion-associated graft-versus-host disease after surgery for bladder cancer. Blood 82 (1993) 326-327
104. Soeda K., Onoda S., Kozu T., et al. A case of fatal graft-versus-host disease following blood transfusion in esophageal cancer documented by homozygous changes of HLA typing. Nippon Geka Gakkai Zasshi 91 (1990) 1040-1043
105. Labotka R.J., and Radvany R. Graft-versus-host disease in rhabdomyosarcoma following transfusion with nonirradiated blood products. Med Pediatr Oncol 13 (1985) 101-104
106. Utkan G., Buyukcelik A., Demir O., et al. Post-transfusion acute graft versus host disease in a 17-year-old girl with a malignant mesenchymal tumor-report of a case. Acta Med Austriaca 30 (2003) 138-141
107. Woods W.G., and Lubin B.H. Fatal graft versus host disease following a blood transfusion in a child with neuroblastoma. Pediatrics 67 (1981) 217-221
108. Kennedy J.S., and Ricketts R.R. Fatal graft v host disease in a child with neuroblastoma following a blood transfusion. J Pediatr Surg 21 (1986) 1108-1109
109. Andersen C.B., Ladefoged S.D., and Taaning E. Transfusion-associated graft-versus-graft and potential graft-versus-host disease in a renal allotransplanted patient. Hum Pathol 23 (1992) 831-834
110. Sola M.A., Espana A., Redondo P., et al. Transfusion-associated acute graft-versus-host disease in a heart transplant recipient. Br J Dermatol 132 (1995) 626-630
111. Wisecarver J.L., Cattral M.S., Langnas A.N., et al. Transfusion-induced graft-versus-host disease after liver transplantation. Documentation using polymerase chain reaction with HLA-DR sequence-specific primers. Transplantation 58 (1994) 269-271
112. Triulzi D.J., and Nalesnik M.A. Microchimerism, GvHD, and tolerance in solid organ transplantation. Transfusion 41 (2001) 419-426
113. Sale G.E., Lerner K.G., Barker E.A., et al. The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol 89 (1977) 621-635
114. Sage D., Stanworth S., Turner D., et al. Diagnosis of transfusion-associated graft-vs.-host disease: The importance of short tandem repeat analysis. Transfus Med 15 (2005) 481-485
115. Uchida S., Wang L., Yahagi Y., et al. Utility of fingernail DNA for evaluation of chimerism after bone marrow transplantation and for diagnostic testing for transfusion-associated graft-versus-host disease. Blood 87 (1996) 4015-4016
116. DePalma L., Bahrami K.R., Kapur S., et al. Amplified fragment length polymorphism analysis in the evaluation of posttransfusion graft-versus-host disease in a child undergoing extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 108 (1994) 182-184
117. Wang L., Juji T., Tokunaga K., et al. Brief report: Polymorphic microsatellite markers for the diagnosis of graft-versus-host disease. N Engl J Med 330 (1994) 398-401
118. Warren L.J., Simmer K., Roxby D., et al. DNA polymorphism analysis in transfusion-associated graft-versus-host disease. J Paediatr Child Health 35 (1999) 98-101
119. Otsuka S., Kimura A., Date Y., et al. Fatal transfusion-associated graft-versus-host disease. Transfusion 34 (1994) 936-937
120. Yasukawa M., Shinozaki F., Hato T., et al. Successful treatment of transfusion-associated graft-versus-host disease. Br J Haematol 86 (1994) 831-836
121. Mori S., Matsushita H., Ozaki K., et al. Spontaneous resolution of transfusion-associated graft-versus-host disease. Transfusion 35 (1995) 431-435
122. Pelszynski M.M., Moroff G., Luban N.L., et al. Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: Implications for preventing transfusion-associated graft-versus-host disease. Blood 83 (1994) 1683-1689
123. Drobyski W., Thibodeau S., Truitt R.L., et al. Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism. Blood 74 (1989) 2285-2294
124. Webb D.K. Preventative policies in transfusion associated graft versus host disease in the treatment of cancer. Arch Dis Child 71 (1994) 532-533
125. Button L.N., DeWolf W.C., Newburger P.E., et al. The effects of irradiation on blood components. Transfusion 21 (1981) 419-426
126. Ramirez A.M., Woodfield D.G., Scott R., et al. High potassium levels in stored irradiated blood. Transfusion 27 (1987) 444-445
127. Moroff G., Holme S., AuBuchon J.P., et al. Viability and in vitro properties of AS-1 red cells after gamma irradiation. Transfusion 39 (1999) 128-134
128. Read E.J., Kodis C., Carter C.S., et al. Viability of platelets following storage in the irradiated state. A pair-controlled study. Transfusion 28 (1988) 446-450
129. Duguid J.K.M., Carr R., and Jenkins J.A. Clinical evaluation of the effects of storage time and irradiation on transfused platelets. Vox Sang 60 (1991) 151-154
130. Sprent J., Anderson R.E., and Miller J.F.A.P. Radiosensitivity of T and B lymphocytes. II. Effect of irradiation on response of T cells to alloantigens. European Journal of Immunology 4 (1974) 204-210
131. Bowden R.A., Slichter S.J., Sayers M., et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 86 (1995) 3598-3603
132. Rebulla P., Bertolini F., Parravicini A., et al. Leukocyte-poor blood components: a purer and safer transfusion product for recipients?. Transfus Med Rev 4 (1990) 19-23
133. Snyder E.L., and Bookbinder M. Role of microaggregate blood filtration in clinical medicine. Transfusion 23 (1983) 460-470
134. Callaerts A.J., Gielis M.L., Sprengers E.D., et al. The mechanism of white cell reduction by synthetic fiber cell filters. Transfusion 33 (1993) 134-138
135. Stainsby D., Jones H., Asher D., et al. Serious hazards of transfusion: A decade of hemovigilance in the UK. Transfus Med Rev 20 (2006) 273-282
136. Hayashi H., Nishiuchi T., Tamura H., et al. Transfusion-associated graft-versus-host disease caused by leukocyte-filtered stored blood. Anesthesiology 79 (1993) 1419-1421
137. Grass J.A., Wafa T., Reames A., et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood 93 (1999) 3140-3147